Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates that core study information is not accessible on the page.
    Difference
    17%
    Check dated 2026-09-20T20:31:03.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    A funding attribution line '2015 ( U.S. NIH Grant/Contract )' was added to the study's records. The site revision tag was updated to 'Revision: v3.6.6' (replacing the previous 'v3.6.5').
    Difference
    0.1%
    Check dated 2026-08-30T17:36:45.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small site update reflected in the page footer/metadata.
    Difference
    0.0%
    Check dated 2026-08-09T12:25:56.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a software/template version update for the page without altering the study content.
    Difference
    0.0%
    Check dated 2026-07-26T00:10:26.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 on the page. This reflects a minor platform build update and does not modify study information or patient-facing content.
    Difference
    0.0%
    Check dated 2026-07-04T13:19:53.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.0 to v3.6.2, indicating a minor platform update. The page's study details and listed locations remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T05:58:47.000Z thumbnail image

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.